Phage Therapy Pharmacology. Calculating Phage Dosing

Advances in Applied Microbiology

Volumn 77, Issue , 2011, Pages 1-40

  Abedon, Stephen ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Bacteriophages; Biocontrol; Decimal reduction time; Minimum bactericidal concentration; Minimum inhibitory concentration; Multiplicity of infection; Phage therapy; Pharmacodynamics; Pharmacokinetics; Pharmacology

Indexed keywords

ANTIMICROBIAL THERAPY; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BIOLOGICAL PEST CONTROL; BOOK; ERADICATION THERAPY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POPULATION GROWTH; BACTERIUM; HUMAN; KINETICS;

BACTERIA (MICROORGANISMS);

BACTERIA; BACTERIAL INFECTIONS; BACTERIOPHAGES; HUMANS; KINETICS;

EID: 80055108749     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387044-5.00001-7     Document Type: Chapter

References (39)

1. Abedon S.T. Selection for lysis inhibition in bacteriophage. J. Theor. Biol. 1990, 146:501-511.
2. Abedon S.T. Phage population growth: Constraints, games, adaptations. Bacteriophage Ecology 2008, 64-93. Cambridge University Press, Cambridge, UK. S.T. Abedon (Ed.).
3. Abedon S.T. Phage, bacteria, and food. Appendix: Rate of adsorption is function of phage density. Bacteriophage Ecology 2008, 321-324. Cambridge University Press, Cambridge, UK. S.T. Abedon (Ed.).
4. Abedon S.T. Impact of phage properties on bacterial survival. Contemporary Trends in Bacteriophage Research 2009, 217-235. Nova Science Publishers, Hauppauge, NY. H.T. Adams (Ed.).
5. Abedon S.T. Kinetics of phage-mediated biocontrol of bacteria. Foodborne Pathog. Dis. 2009, 6:807-815.
6. Abedon S.T. Phage evolution and ecology. Adv. Appl. Microbiol. 2009, 67:1-45.
7. Abedon S.T. Bacteriophages and biofilms. Biofilms: Formation, Development and Properties 2010, 1-58. Nova Science Publishers, Hauppauge, NY. W.C. Bailey (Ed.).
8. Abedon S.T. The 'nuts and bolts' of phage therapy. Curr. Pharm. Biotechnol. 2010, 11:1.
9. Abedon S.T. Bacteriophages and Biofilms: Ecology, Phage Therapy, Plaques 2011, Nova Science Publishers, Hauppauge, NY.
10. Abedon S.T. Lysis from without. Bacteriophage 2011, 1:46-49.
11. Abedon S.T. Envisaging bacteria as phage targets. Bacteriophage 2011, 1. http://www.landesbioscience.com/journals/bacteriophage/article/17281/.
12. Abedon S.T. Bacteriophages as drugs: The pharmacology of phage therapy. Phage Therapy: Current Research and Applications 2012, Caister Academic Press, Norfolk, UK, [accepted for publication]. J. Borysowski, R. Miêdzybrodzki, A. Górski (Eds.).
13. Abedon S.T. Phage therapy best practices. Bacteriophages in Health and Disease 2012, CABI Press, Oxford, UK, [accepted for publication]. P. Hyman, S.T. Abedon (Eds.).
14. Abedon S.T., Thomas-Abedon C. Phage therapy pharmacology. Curr. Pharm. Biotechnol. 2010, 11:28-47.
15. Abedon S.T., Herschler T.D., Stopar D. Bacteriophage latent-period evolution as a response to resource availability. Appl. Environ. Microbiol. 2001, 67:4233-4241.
16. Abedon S.T., Kuhl S.J., Blasdel B.G., Kutter E.M. Phage treatment of human infections. Bacteriophage 2011, 1:66-85.
17. Ackermann H.-W. 5500 phages examined in the electron microscope. Arch. Virol. 2007, 152:227-243.
18. Adams M.H. Bacteriophages 1959, InterScience, New York.
19. Balogh B., Jones J.B., Iriarte F.B., Momol M.T. Phage therapy for plant disease control. Curr. Pharm. Biotechnol. 2010, 11:48-57.
20. Cairns B.J., Payne R.J.H. Bacteriophage therapy and the mutant selection window. Antimicrob. Agents Chemother. 2008, 52:4344-4350.
21. Carlson K. Working with bacteriophages: Common techniques and methodological approaches. Bacteriophages: Biology and Application 2005, 437-494. CRC Press, Boca Raton, FL. E. Kutter, A. Sulakvelidze (Eds.).
22. Chan B.K., Abedon S.T. Bacteriophage adaptation, with particular attention to issues of phage host range. Bacteriophages in Dairy Processing 2011, Nova Science Publishers, Hauppauge, NY. A. Quiberoni, J. Reinheimer (Eds.).
23. Doermann A.H. Lysis and lysis inhibition with Escherichia coli bacteriophage. J. Bacteriol. 1948, 55:257-275.
24. Goodridge L.D. Phages, bacteria, and food. Bacteriophage Ecology 2008, 302-331. Cambridge University Press, Cambridge, UK. S.T. Abedon (Ed.).
25. Goodridge L.D. Designing phage therapeutics. Curr. Pharm. Biotechnol. 2010, 11:15-27.
26. Hagens S., Loessner M.J. Bacteriophage for biocontrol of foodborne pathogens: Calculations and considerations. Curr. Pharm. Biotechnol. 2010, 11:58-68.
27. Hudson J.A., Bigwood T., Premaratne A., Billington C., Horn B., McIntyre L. Potential to use ultraviolet-treated bacteriophages to control foodborne pathogens. Foodborne Pathog. Dis. 2010, 7:687-693.
28. Hyman P., Abedon S.T. Practical methods for determining phage growth parameters. Methods Mol. Biol. 2009, 501:175-202.
29. Hyman P., Abedon S.T. Bacteriophage host range and bacterial resistance. Adv. Appl. Microbiol. 2010, 70:217-248.
30. Kasman L.M., Kasman A., Westwater C., Dolan J., Schmidt M.G., Norris J.S. Overcoming the phage replication threshold: A mathematical model with implications for phage therapy. J. Virol. 2002, 76:5557-5564.
31. Kutter E., De Vos D., Gvasalia G., Alavidze Z., Gogokhia L., Kuhl S., Abedon S.T. Phage therapy in clinical practice: Treatment of human infections. Curr. Pharm. Biotechnol. 2010, 11:69-86.
32. Levin B.R., Bull J.J. Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2004, 2:166-173.
33. Loc-Carrillo C., Abedon S.T. Pros and cons of phage therapy. Bacteriophage 2011, 1:111-114.
34. Murray A.G., Jackson G.A. Viral dynamics: A model of the effects of size, shape, motion, and abundance of single-celled planktonic organisms and other particles. Mar. Ecol. Prog. Ser. 1992, 89:103-116.
35. Payne R.J.H., Jansen V.A.A. Understanding bacteriophage therapy as a density-dependent kinetic process. J. Theor. Biol. 2001, 208:37-48.
36. Payne R.J.H., Jansen V.A.A. Pharmacokinetic principles of bacteriophage therapy. Clin. Pharmacokinet. 2003, 42:315-325.
37. Payne R.J.H., Phil D., Jansen V.A.A. Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals. Clin. Pharmacol. Ther. 2000, 68:225-230.
38. Stent G.S. Molecular Biology of Bacterial Viruses 1963, WH Freeman and Co., San Francisco, CA.
39. Wang I.-N., Dykhuizen D.E., Slobodkin L.B. The evolution of phage lysis timing. Evol. Ecol. 1996, 10:545-558.